tiprankstipranks
Clarus Therapeutics Holdings (CRXT)
OTHER OTC:CRXT
US Market

Clarus Therapeutics Holdings (CRXT) Stock Investors

0 Followers
Based on 561,678 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CRXT
On average, investors allocate 1.91% of their portfolios to CRXT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 561,678 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CRXT

0.2%
Last 7
Days
2.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CRXT, out of 561,678 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CRXT Investor Activity

No data currently available
Based on the activity of 10,782 investors who made their portfolios public
The table shows changes in CRXT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CRXT Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
SNDL
3.92%
-0.53%
-1.48%
637.84M
Basic Materials
Workhorse Group
3.29%
-0.57%
-0.84%
489.59M
Consumer Goods
ContextLogic
3.86%
-0.35%
-0.94%
810.70M
Consumer Goods
BioNano Genomics
4.54%
-0.30%
-0.53%
670.22M
Healthcare
Fisker
4.10%
-0.52%
-0.75%
2.51B
Consumer Goods
Blink Charging Co
3.66%
-0.44%
-0.28%
994.04M
Services
Luminar Technologies
3.39%
-0.14%
+1.69%
2.91B
Industrial Goods
Nokia
5.75%
-0.23%
-0.63%
28.29B
Technology
Paysafe
3.22%
-0.44%
-1.77%
1.26B
Services
Nano Dimension
3.60%
-0.41%
-1.46%
674.42M
Industrial Goods
Based on the activity of 561,678 active portfolios
Open your Smart Portfolio

CRXT Investor Analysis

CRXT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
25.0%
of CRXT holders
are under 35
Average Segment Performance
Average P/E Ratio18.87
Beta1.35
Dividend Yield4.02%
CRXT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
54.2%
of CRXT holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.88
Beta1.33
Dividend Yield4.56%
CRXT investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
20.8%
of CRXT holders
are over 55
Average Segment Performance
Average P/E Ratio20.54
Beta1.13
Dividend Yield4.18%
Overview of age group and performance of CRXT stock investors
See who invests in CRXT according to age group and performance.

FAQ

How many retail Investors hold CRXT?
<0.1% of TipRanks' retail investors hold CRXT in their portfolios.
    What is CRXT Investor Sentiment?
    CRXT’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of CRXT in the last 7 days?
      ▲ 0.2% of TipRanks' retail investors changed their holding of CRXT in the last 7 days.
        What percentage of retail investors changed their holding of CRXT in the last 30 days?
        ▲ 2.9% of TipRanks' retail investors changed their holding of CRXT in the last 30 days.
          What is the average age of retail investors who hold CRXT?
          The average age of CRXT Holders is between 35–55.
            What other stocks have CRXT investors also bought?
            CRXT Investors also bought SNDL, WKHS, WISH, BNGO, FSR, BLNK, LAZR, NOK, PSFE, NNDM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AAgilent
              AVEOAVEO Pharma
              CPRXCatalyst Pharma
              CYHCommunity Health
              FMSFresenius Medical Care
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis